The East Bay Business Times (Free subscription) | 10/07/2008
Entelos Inc. said late Wednesday that Eli Lilly and Co. exercised its right to a perpetual license to Entelos' DrugMatrix database and additional customized report services. (LLY)
bizjournals (Free subscription) | 10/07/2008
Entelos Inc. said late Wednesday that Eli Lilly and Co. exercised its right to a perpetual license to Entelos' DrugMatrix database and additional customized report services. (LLY)
bizjournals (Free subscription) | 16/04/2008
Life sciences company Entelos Inc. said late Tuesday it will partner with Unilever plc to develop the next generation Physiolab platform.
Medical News Today (Free subscription) | 11/04/2008
The American Diabetes Association (ADA) and Entelos, Inc. (LSE: ENTL) announced extending its in silico (computer simulation) diabetes research center capability and offering free access to Entelos' Realab™ "virtual mice" testing platform to all ADA health professional members.
bizjournals (Free subscription) | 21/01/2008
Entelos Inc. said it signed a research deal with UCB Pharma SA to study rheumatoid arthritis.
The San Francisco Business Times (Free subscription) | 21/01/2008
Entelos Inc. signed a research deal with Belgian firm UCB Pharma SA to study rheumatoid arthritis.
bizjournals (Free subscription) | 13/11/2007
Life sciences company Entelos Inc. said Tuesday that Pfizer Inc. signed an agreement to expand research using the Entelos Cardiovascular PhysioLab platform. (PFE)
bizjournals (Free subscription) | 31/10/2007
Entelos Inc., a life sciences company that uses predictive technologies with virtual patients for drug discovery and development, said Wednesday it raised $1.5 million from a Pfizer share purchase. (PFE)
The San Francisco Business Times (Free subscription) | 30/08/2007
Life science company Entelos Inc. will buy Iconix Biosciences Inc. for $14.1 million in stock.
Red Orbit (Free subscription) | 30/08/2007
Entelos, Inc. (LSE:ENTL), a leading life sciences company that leverages its proprietary in silico disease models, known as PhysioLab® platforms, to develop drugs and support pharmaceutical R&D, is pleased to announce that it has entered into an agreement to acquire Iconix Biosciences, Inc.
Business Wire (Free subscription) | 06/08/2007
FOSTER CITY, Calif.--(BUSINESS WIRE)--Entelos, Inc. (LSE:ENTL), a leading life sciences company building predictive computer models and “virtual patients
